Receptor expression-enhancing protein 2, GTP cyclohydrolase 1, and Cdc42 effector protein 3 were detected in 75% of NSCLC patients with N2 features, but only in 17% of patients with N1 features and 20% of patients with N0 features. This evidence concerns the gene CDC42EP3 and non-small cell lung carcinoma.